<DOC>
	<DOCNO>NCT00490373</DOCNO>
	<brief_summary>This study pemetrexed patient metastatic unresectable pancreatic cancer progress first line chemotherapy gemcitabine .</brief_summary>
	<brief_title>Trial Pemetrexed Patients With Pancreatic Cancer Which Can Treated With Surgery Metastatic</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Histological cytological diagnosis adenocarcinoma pancreas locally advance ( Stage II , III ) metastatic ( Stage IV ) , stag American Joint Committee Cancer ( AJCC ; Protocol Attachment S041.2 ; Fleming et al . 1997 ) , amenable resection curative intent . Prior systemic first line chemotherapy gemcitabine single agent combination regimen include gemcitabine ( one prior systemic chemotherapy allow ) . Unidimensionally measurable disease accord RECIST criterion ( Therasse et al . 2000 ) , define : At least one lesion accurately measure least one dimension , long diameter great equal 2 cm conventional technique great equal 1.0 cm spiral CT scan . Ultrasound Xray NOT allow measure follow lesion . Prior radiation equal great 25 % bone marrow ( Cristy Eckerman 1987 ) Prior immunotherapy , biological therapy , and/or hormonal therapy pancreas cancer . Prior systemic chemotherapy 5FU . Patient yet recover acute toxic effect treatment prior study enrollment . Radiotherapy within last 4 week study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
</DOC>